+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Angiotensin II Receptor"

From
From
From
From
From
From
Antihypertensives: Global Markets to 2023 - Product Thumbnail Image

Antihypertensives: Global Markets to 2023

  • Report
  • January 2019
  • 144 Pages
  • Global
From
From
From
Angiotensin type 1 receptor antagonists - Pipeline Insight, 2022 - Product Thumbnail Image

Angiotensin type 1 receptor antagonists - Pipeline Insight, 2022

  • Drug Pipelines
  • January 2022
  • 60 Pages
  • Global
From
From
From
Investigation Report on China's Telmisartan Market, 2018-2022 - Product Thumbnail Image

Investigation Report on China's Telmisartan Market, 2018-2022

  • Report
  • December 2018
  • 30 Pages
  • China
From
From
Type 2 Angiotensin II Receptor - Pipeline Review, H2 2020 - Product Thumbnail Image

Type 2 Angiotensin II Receptor - Pipeline Review, H2 2020

  • Drug Pipelines
  • October 2020
  • 51 Pages
  • Global
From
From
Loading Indicator

The Angiotensin II Receptor market is a segment of the Cardiovascular Drugs market. It is composed of drugs that target the Angiotensin II Receptor, a protein found in the body that plays a role in regulating blood pressure. These drugs are used to treat hypertension, congestive heart failure, and other cardiovascular diseases. They work by blocking the action of Angiotensin II, which helps to reduce blood pressure. The Angiotensin II Receptor market is highly competitive, with many companies offering similar products. Some of the major players in the market include Novartis, Merck, Pfizer, Sanofi, and AstraZeneca. These companies have developed a range of drugs that target the Angiotensin II Receptor, including ACE inhibitors, angiotensin receptor blockers, and angiotensin-converting enzyme inhibitors. Show Less Read more